Longevity Medical Tests: Biomarkers and Health Screenings
Preventive medicine is the foundation of longevity. The difference between dying at seventy and thriving past ninety often comes down to detecting and addressing dysfunction early, before it becomes disease. Medical tests designed to assess biological age and identify early risk factors allow individuals to intervene with lifestyle changes, supplementation, or medical treatments before damage accumulates. Understanding which tests provide useful information, how to interpret results, and how to act on them is essential for anyone serious about extending their healthspan.
Biomarkers of Aging
Biological age is distinct from chronological age. Two individuals born in the same year can have vastly different biological ages based on their genetics, lifestyle, and environmental exposures. Measuring biological age requires assessing key biomarkers that reflect the function of major physiological systems.
Inflammatory Markers
Chronic low-grade inflammation is one of the most reliable predictors of age-related decline. Three inflammatory markers are particularly useful for longevity assessment.
High-sensitivity C-reactive protein (hs-CRP) measures systemic inflammation and is a strong predictor of cardiovascular disease, even in people with normal cholesterol levels. Levels below 1.0 milligrams per liter are optimal. Levels above 3.0 indicate elevated risk. The Jupiter trial, a landmark study involving over 17,000 participants, found that people with elevated hs-CRP benefited significantly from statin therapy even when their cholesterol was normal.
Interleukin-6 (IL-6) is another key inflammatory cytokine. Elevated IL-6 predicts not only cardiovascular disease but also frailty, cognitive decline, and mortality in older adults. The InCHIANTI study found that older adults with the highest IL-6 levels had twice the risk of dying over seven years compared to those with the lowest levels.
Fibrinogen is a blood protein involved in clotting that rises with inflammation. Elevated fibrinogen increases the risk of blood clots, stroke, and cardiovascular disease. Levels should ideally be below 400 milligrams per deciliter.
Glucose Metabolism Markers
How the body handles glucose is a critical determinant of aging rate. Chronically elevated blood sugar damages proteins through glycation, forming advanced glycation end products (AGEs) that stiffen tissues and accelerate aging.
Fasting blood glucose should ideally be below 100 milligrams per deciliter. Levels between 100 and 125 indicate prediabetes, and levels above 126 indicate diabetes. Hemoglobin A1c reflects average blood glucose over the previous three months. Optimal levels are below 5.7 percent. Each one-point increase in A1c above 6.0 is associated with a significant increase in cardiovascular risk.
Fasting insulin is an earlier and more sensitive marker of metabolic dysfunction. High fasting insulin indicates insulin resistance, which often precedes elevated glucose by years. Optimal fasting insulin is below 8 microinternational units per milliliter. Levels above 12 suggest significant insulin resistance, even when glucose is normal.
Hormone Panels
Hormones regulate virtually every aspect of aging. Testing should include at minimum thyroid panel (TSH, free T3, free T4), reproductive hormones (testosterone, estradiol, progesterone), cortisol, and DHEA-S.
Testosterone declines with age in both men and women. Low testosterone is associated with reduced muscle mass, low bone density, fatigue, depression, and increased mortality. Optimal total testosterone for men is above 500 nanograms per deciliter, though reference ranges vary by lab. For women, optimal levels depend on age and menopausal status.
Cortisol should follow a diurnal rhythm, with high levels in the morning and low levels at night. A flattened rhythm suggests chronic stress and is associated with accelerated aging. The cortisol awakening response, measured 30 to 45 minutes after waking, is a sensitive marker of adrenal function.
Lipid Profiles
Standard lipid panels measure total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. For longevity assessment, advanced lipid testing provides additional information.
Apolipoprotein B (ApoB) measures the number of atherogenic particles in the blood and is more predictive of cardiovascular risk than LDL cholesterol alone. Optimal ApoB levels are below 80 milligrams per deciliter. Lipoprotein(a) is a genetic variant of LDL that is independently associated with heart disease risk. Levels above 50 milligrams per deciliter require aggressive management of other risk factors.
The triglyceride-to-HDL ratio is a simple and useful marker of metabolic health. A ratio below 2.0 is optimal. Ratios above 4.0 suggest insulin resistance and increased cardiovascular risk.
Advanced Longevity Tests
Beyond standard blood work, several specialized tests provide deeper insight into biological aging.
Telomere Length Measurement
Telomere length testing measures the average length of telomeres in white blood cells. Shorter telomeres are associated with increased risk of age-related disease and premature mortality. Several commercial laboratories offer telomere testing using quantitative PCR or flow cytometry with fluorescence in situ hybridization (flow-FISH).
Interpreting telomere results requires comparing individual values to age-matched reference ranges. Telomere length declines with age, but the rate of decline varies between individuals. Repeat testing every two to three years can track the trajectory. A faster-than-expected decline signals a need for lifestyle intervention.
DNA Methylation Age (Epigenetic Clock)
Epigenetic age testing uses DNA methylation patterns to estimate biological age. The Horvath clock, developed by Steve Horvath, analyzes methylation at 353 specific sites on the genome. The GrimAge clock and PhenoAge clock are newer versions that are more predictive of mortality and age-related disease.
The difference between epigenetic age and chronological age, called epigenetic age acceleration, is a powerful predictor of health outcomes. An acceleration of five years is associated with a 15 to 20 percent increase in mortality risk. Longitudinal testing can track how lifestyle interventions affect biological age.
Advanced Cardiovascular Testing
Coronary artery calcium (CAC) scoring uses CT imaging to measure calcified plaque in the coronary arteries. A score of zero indicates no detectable plaque and very low future heart attack risk. Scores above 100 indicate significant plaque burden requiring aggressive risk factor management. CAC scoring is the single best predictor of future cardiovascular events.
Carotid intima-media thickness (CIMT) uses ultrasound to measure the thickness of the carotid artery walls. Increased thickness indicates early atherosclerosis and predicts stroke and heart attack risk. CIMT can detect arterial changes years before symptoms appear.
Vitamin and Nutrient Testing
Vitamin D levels should be maintained between 50 and 80 nanograms per milliliter. Vitamin D deficiency is associated with increased mortality, immune dysfunction, and bone loss. Most people require supplementation to reach optimal levels.
Omega-3 index measures the percentage of EPA and DHA in red blood cell membranes. An index above 8 percent is associated with lower cardiovascular risk and slower telomere shortening. The Omega-3 index is modifiable through increased fish consumption or supplementation.
Magnesium, zinc, selenium, and B vitamins all play essential roles in cellular function and aging. Testing can identify deficiencies that accelerate aging and are easily correctable.
Thyroid Function
Thyroid hormones regulate metabolism, body temperature, and cellular energy production. Subclinical hypothyroidism, in which TSH is elevated but thyroid hormones are still within normal range, becomes more common with age and is associated with increased cardiovascular risk and cognitive decline. Optimal TSH levels for longevity are between 0.5 and 2.5 milli-international units per liter, though reference ranges vary by laboratory. Free T3 and free T4 provide additional information about thyroid function beyond TSH alone.
Building a Testing Schedule
A longevity testing schedule should include annual or semi-annual assessments. Baseline testing establishes current status and identifies priorities. Repeat testing tracks progress and adjusts interventions.
Annual or semi-annual blood work should include a complete metabolic panel, complete blood count, lipid panel with ApoB, hs-CRP, hemoglobin A1c, fasting insulin, thyroid panel, and vitamin D. Every two to three years, repeat telomere length or epigenetic age testing. CAC scoring is recommended once between ages 40 and 60 for men and 50 and 70 for women, with repeat testing every five to seven years if indicated.
FAQ
How do I find a doctor who offers longevity testing? Functional medicine physicians and integrative medicine practitioners are most likely to offer comprehensive longevity testing. Many direct primary care and concierge medicine practices also provide advanced testing. Online services offer direct-to-consumer testing, but interpreting results with a knowledgeable practitioner is important.
Are these tests covered by insurance? Standard blood work and lipid panels are typically covered. Advanced tests such as telomere length, epigenetic age, and coronary calcium scoring are often considered experimental and may require out-of-pocket payment. Costs vary widely.
Can I improve my biomarker scores? Yes. Most biomarkers of aging respond to lifestyle interventions. Exercise improves glucose metabolism, inflammatory markers, and lipid profiles. Diet affects nearly every biomarker. Stress reduction and sleep optimization improve hormone balance and inflammation. The biomarker trajectory can be improved at any age.
What is the single most important test for longevity? High-sensitivity C-reactive protein provides the most information per dollar spent. It captures inflammation, which underlies most age-related diseases. Combined with hemoglobin A1c and apolipoprotein B, it provides a powerful three-marker assessment of aging risk.
When should I start longevity testing? Baseline testing in the thirties or early forties provides a reference point and identifies early metabolic dysfunction before it becomes disease. Testing is valuable at any age, but earlier testing allows more time for intervention.